Locemia Solutions ULC

On the heels of Amgen Inc. and Allergan PLC launching the first two oncology biosimilars in the US, the US Food and Drug Administration approved a pair of new biosimilars just days later: Pfizer

BioVentures Investors LLC has closed an $87m fund, which will be dedicated to investments in early stage medical device and diagnostics companies. This is the fourth – and largest – fund for BioVentu

Eli Lilly & Co. is looking to use its strong position in diabetes to segue into other related therapeutic areas, including renal diseases, nephropathy and cardiovascular disease. The Indianapolis co

Eli Lilly & Co. is looking to use its strong position in diabetes to segue into other related therapeutic areas, including renal diseases, nephropathy and cardiovascular disease. The Indianapolis co